CLOSED bundle: Intracranial Pressure and Optic Nerve Sheath Diameter With CLOSED Bundle

Sponsor
IRCCS Istituto delle Scienze Neurologiche di Bologna (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06057155
Collaborator
(none)
150
1
30
5

Study Details

Study Description

Brief Summary

The design of the present study will be a multicenter prospective observational protocol. Approximately 150 patients will be recruited over the 24-month period with Acute Brain Injury (trauma brain injury, intra-cerebral hemorrhage, subarachnoid hemorrhage, ischemic stroke), who in their acute phase of intensive care unit care require placement of a catheter capable of monitoring intracranial pressure (intra parenchymal catheter or external vetricular shunt). In addition to all the intensive care provided by the most recent guidelines, patients will undergo measurement of optic nerve sheath diameter through ultrasonography. At least, three measurements will be performed within the first 3 hours after admission, within the first 24-48 hours, and at each invasive intracranial pressure value greater than 18 cmH2O. Those patients with intracranial pressure values greater than 30 mmHg. at the first intracranial pressure measurement, patients with eyeball disease or trauma will be excluded. Measurements will be performed all following the CLOSED bundle.

Analysis of the results will include correlation between the invasive pressure values and the mean value of optic nerve guine diameter measurements in the two projections (sagittal and transverse). In addition, the correlation of the absolute value of invasive pressure detected with the ratio of the optic nerve sheath diameter measurement to the eyeball diameter measured always ultrasound (antromorphic measurement) will be sought.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: ultrasound optic nerve sheath diameter assessment

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Correlation Between Intracranial Pressure and Optic Nerve Sheath Diameter Measured With CLOSED Bundle in Patients With Acute Brain Injury: Multicenter Observational Study
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Jun 1, 2026

Arms and Interventions

Arm Intervention/Treatment
acute brain injury

Intra Cerebral Hemorrhage Subarachnoid Hemorrhage, Aneurysmal Trauma, Brain Stroke, Ischemic

Diagnostic Test: ultrasound optic nerve sheath diameter assessment
ultrasound optic nerve sheath diameter assessment

Outcome Measures

Primary Outcome Measures

  1. correlation between invasive intra-cranial pression assessment and ultasound ONSD assessment [3, 24, 48 hours after admission]

Secondary Outcome Measures

  1. correlation between invasive intra-cranial pression assessment and ultasound ratio of ONSD assessment and eyeball transverse diameter [3, 24, 48 hours after admission]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

acute brain injury patients with an invasive intra-cranial pressure monitoring

-

Exclusion Criteria:

patients affected by disease or trauma of eye ball patients or relatives that don't want to participate to the study

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna Italy

Sponsors and Collaborators

  • IRCCS Istituto delle Scienze Neurologiche di Bologna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Raffaele Aspide, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna
ClinicalTrials.gov Identifier:
NCT06057155
Other Study ID Numbers:
  • 6669
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Raffaele Aspide, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2023